- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
BALAXI PHARMACEUTICALS LIMITED — Board Meeting, 05-08-2026: Outcome of Board Meeting
05-08-2026 | 01:51 pm
05-08-2026 | 01:51 pm
Balaxi Pharma reported Q1 consolidated revenue of ₹80.68 Cr & net profit of ₹1.30 Cr. The board noted its Jadcherla plant began commercial production with 2 products, secured approvals for 29 more, and is on track for WHO-GMP certification.
No comments yet. Be the first to comment!